Point-of-Care Clinical Decision-Making: Test Your Skills in Evidence-Based HCV Management

Released On
November 30, 2021

Expires On
November 30, 2022

Media Type

Completion Time
85 minutes

Gastroenterology, Hepatology, Infectious Disease, Primary Care


Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Purdue University College of Pharmacy and Integritas Communications.


Supported by educational grants from Gilead Sciences, Inc., and AbbVie Inc.

Credit Available

  • Physicians — maximum of 1.25 AMA PRA Category 1 Credits

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This educational activity is intended for infectious disease specialists, gastroenterologists, hepatologists, primary care physicians, nurse practitioners, physician assistants, and other health care providers who interact with HCV-positive patients.

Program Overview

This virtual activity provides dynamic content, divided among 3 distinct clinical scenarios. Each clinical scenario will involve the participant’s decision-making and interaction with 2 virtual clinicians to gain their perspectives and feedback on management of hepatitis C virus (HCV) care and cure. One virtual clinician is a peer with whom the learner is collaborating, while the other is an expert in managing the given HCV-related circumstances. Scenarios also include virtual patient interactions and provide examples of best practices in patient-centered care for support of adherence, satisfaction, and outcomes.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Apply prevailing guidelines for HCV universal screening and risk-based periodic testing.
  • Provide guideline-based HCV care for treatment-naive patients with HCV monoinfection or HCV in HIV/HCV coinfection.
  • Engage in patient-centered care across the HCV-care continuum, incorporating harm-reduction principles and practices.


Andrew J. Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology
Department of Medicine
Duke University School of Medicine
Durham, North Carolina

Stacey B. Trooskin, MD, PhD, MPH

Chief Medical Officer
Director of Viral Hepatitis Programs
Jonathan Lax Treatment Center
Philadelphia FIGHT
Philadelphia, Pennsylvania

Patient Perspective Interview

Jennifer E. Slepin, MSN, RN, PHN

Resource Nurse, Hepatology Duke Private Diagnostic Clinic Executive Director HepCarestream/Hepatitis C Clinical Education Group, Inc. Durham, North Carolina

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Integritas Communications. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Purdue University College of Pharmacy designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

Faculty, Staff, and Reviewer Disclosure Statement

All faculty, staff, and reviewers involved in the planning, review, or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any commercial financial affiliations with ineligible entities related to the content of the presentation or enduring material. Full disclosure must be made in writing to the audience prior to the activity.

All additional planning committee members, staff, and reviewers of Integritas Communications and Purdue University College of Pharmacy have no relationships to disclose.

The faculty reported the following financial relationships or relationships to products or devices they have with ineligible entities related to the content of this CME activity:

Andrew J. Muir, MD

  • Grants/Research Support: AbbVie Inc., Gilead Sciences, Inc., Merck & Co. Inc.
  • Advisory Board: AbbVie Inc., Gilead Sciences, Inc.

Stacey B. Trooskin, MD, PhD, MPH

  • Grants/Research Support/Advisory Board: Gilead Sciences, Inc.

Jennifer E. Slepin, MSN, RN, PHN: Nothing to report

These relationships have been reviewed and mitigated through peer-review of content by individual without relevant financial relationship.

Instructions to Receive Credit

  • Participants must review all activity information, including the pre-test, learning objectives, faculty disclosure information, simulation scenario(s) and post-activity evaluation.
  • To view the first simulation scenario, launch the simulation from the link provided using a PC, Mac, Tablet, or Phone with a 4G or higher internet connection.
  • Interact appropriately to satisfy each objective to unlock the next objective and view the next simulation scenario.
  • The simulation will track your progress until all scenario objectives are complete.
  • Exit the simulation at any time, and your progress will be saved so you can return to finish at a later time.
  • As you complete each scenario (1 minimum, 3 total), you will qualify for increasing levels of CE credit (ranging from 0.5 to 1.25 credits). Click or tap "Credit" to determine your CE credit status.
  • Upon successful completion of the evaluation, you can download/print a certificate of credit immediately via the browser.

For information about the accreditation of this program, please contact Dawn Sinclair at The Purdue University College of Pharmacy at sinclaid@purdue.edu or 765-494-5457. For questions regarding pharmacy CE credit and reports please contact: pharmacy-cecr@purdue.edu.

System Requirements

Any modern phone or tablet with at least 2GB of RAM (typically 3-4 years old or newer), or a PC/Mac that is 5 years old or newer. A good user experience requires a broadband connection of 4G or better via a modern web browser (Chrome, Firefox, Safari, or Edge; Internet Explorer is not supported).

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Purdue University College of Pharmacy and Integritas Communications do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

For information about the accreditation of this program, please contact Dawn Sinclair at The Purdue University College of Pharmacy at sinclaid@purdue.edu or 765-494-5457. For questions regarding pharmacy CE credit and reports please contact: pharmacy-cecr@purdue.edu.

Copyright Statement

This CME simulation activity is licensed to Integritas Communications, LLC. Copyright © 2021 Syandus Inc and Integritas Communications, LLC. All rights reserved. No part of this simulation activity may be reproduced without written permission from Integritas Communications, LLC and Syandus Inc.
Syandus Link: https://www.syandus.com/medical-education